biotech
Bio-AnalystSupplement research
person

5-HTP

Selected research topic

Cognition

Changes were observed before and after use, but they cannot be attributed to this ingredient.

Some publications still need interpretation checks and are kept separate from the findings below.

Publications for this topic
2
Human comparison publications
0
Publications needing review
1

Findings in the studies

  • MoCA score

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Single ingredient · 12 weeks
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • General population
      • Primary outcome
      • Within-group comparison
      • Timepoint: 12 weeks
      • Study comparison: Within-5-HTP-group increase over time; abstract reports no treatment-by-group effect

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (1)
  • looking duration · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Human studies reported a within-group change in MoCA score.

Single-ingredient studies · Human studies · within-group comparison

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 45.9 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 56

Papers linked to this topic 2 · distinct papers 2 · comparison findings need further review · papers needing additional review 1

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • looking duration: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • MoCA score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

MoCA score

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

looking duration

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

distractibility1 papers
Acute 5-hydroxytryptophan administration did not produce a significant positive effect on distractibility in adults with high or low ADHD traits, and 19.6% experienced fatigue, nausea, or vomiting.Human studies · Randomized controlled trial